ReviewCNS drugs2022
The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder.
Maria Carolina Bittencourt Gonçalves et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it